Search results
Results from the WOW.Com Content Network
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.
For premium support please call: 800-290-4726 more ways to reach us
Glaxo misses both earnings and sales estimates in the fourth quarter of 2019. The company initiates separation program to split itself into two standalone units. Stock down.
Glaxo's (GSK) COVID-19 solutions, newer respiratory and HIV drugs are likely to have driven fourth-quarter sales. The performance of vaccines during Q4 remains to be seen.
For premium support please call: 800-290-4726 more ways to reach us
Dame Emma Natasha Walmsley DBE (born June 1969) is the chief executive officer (CEO) of GSK plc. [1] She succeeded Sir Andrew Witty, who retired in March 2017. [2] Before GSK, she worked for L'Oréal for 17 years, and was a non-executive director of Diageo until September 2016. [3] She grew up in Barrow-in-Furness, Cumbria, England.
On April 19, 2012, GlaxoSmithKline (GSK) made a takeover bid for HGS, offering $13.00 per share for a total valuation of $2.59 billion. [9] The HGS board "...in consultation with independent financial and legal advisors, has carefully reviewed and considered the GSK offer and has determined that the offer does not reflect the value inherent in ...
Glaxo misses both earnings and sales estimates in the second quarter of 2020. Stock down. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 more ...